New high efficacy remedies of animal origin

摘要

The technology is proposed to derive lyophilized medicaments from both mono- and polycultural intact allogenic and xenogenic parenchymatous cells for transitory hepatoprotective therapy in acute hepatic deficiency, including that in terminal states.